235 related articles for article (PubMed ID: 10814523)
41. Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA.
Seronie-Vivien S; Pradines A; Couderc B; Clamagirand C; Berg D; Soula G; Favre G
Cell Growth Differ; 1995 Nov; 6(11):1415-23. PubMed ID: 8562480
[TBL] [Abstract][Full Text] [Related]
42. Characterization of human bone morphogenetic protein (BMP)-4 and -7 gene promoters: activation of BMP promoters by Gli, a sonic hedgehog mediator.
Kawai S; Sugiura T
Bone; 2001 Jul; 29(1):54-61. PubMed ID: 11472891
[TBL] [Abstract][Full Text] [Related]
43. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL
Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
[TBL] [Abstract][Full Text] [Related]
44. Lactone form 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) stimulate the osteoblastic differentiation of mouse periodontal ligament cells via the ERK pathway.
Kim IS; Jeong BC; Kim OS; Kim YJ; Lee SE; Lee KN; Koh JT; Chung HJ
J Periodontal Res; 2011 Apr; 46(2):204-13. PubMed ID: 21198644
[TBL] [Abstract][Full Text] [Related]
45. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes.
Helvering LM; Sharp RL; Ou X; Geiser AG
Gene; 2000 Oct; 256(1-2):123-38. PubMed ID: 11054542
[TBL] [Abstract][Full Text] [Related]
46. Transfilter bone induction by Chinese hamster ovary (CHO) cells transfected by DNA encoding bone morphogenetic protein-4.
Takaoka K; Yoshikawa H; Hashimoto J; Ono K; Matsui M; Nakazato H
Clin Orthop Relat Res; 1994 Mar; (300):269-73. PubMed ID: 8131348
[TBL] [Abstract][Full Text] [Related]
47. Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2-independent manner.
Izumo N; Fujita T; Nakamuta H; Koida M
Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):389-94. PubMed ID: 11771853
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of bone formation in vitro and in rodents by statins.
Mundy G; Garrett R; Harris S; Chan J; Chen D; Rossini G; Boyce B; Zhao M; Gutierrez G
Science; 1999 Dec; 286(5446):1946-9. PubMed ID: 10583956
[TBL] [Abstract][Full Text] [Related]
49. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Yoneda T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
[No Abstract] [Full Text] [Related]
50. Mevalonate reverses the developmental arrest of preimplantation mouse embryos by Compactin, an inhibitor of HMG Co A reductase.
Surani MA; Kimber SJ; Osborn JC
J Embryol Exp Morphol; 1983 Jun; 75():205-23. PubMed ID: 6886611
[TBL] [Abstract][Full Text] [Related]
51. Simvastatin induces the odontogenic differentiation of human dental pulp stem cells in vitro and in vivo.
Okamoto Y; Sonoyama W; Ono M; Akiyama K; Fujisawa T; Oshima M; Tsuchimoto Y; Matsuka Y; Yasuda T; Shi S; Kuboki T
J Endod; 2009 Mar; 35(3):367-72. PubMed ID: 19249597
[TBL] [Abstract][Full Text] [Related]
52. Simvastatin inhibits the division and induces neurite-like outgrowth in PC12 cells.
Sato-Suzuki I; Murota S
Neurosci Lett; 1996 Dec; 220(1):21-4. PubMed ID: 8977139
[TBL] [Abstract][Full Text] [Related]
53. BMP-Id pathway targeted by cholesterol myristate suppresses the apoptosis of PC12 cells.
Chen DF; Cao JH; Liu Y; Wu Y; Du SH; Li H; Zhou JH; Li YW; Zeng HP; Hua ZC
Brain Res; 2011 Jan; 1367():33-42. PubMed ID: 20970407
[TBL] [Abstract][Full Text] [Related]
54. Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor.
Fujii Y; Norihisa K; Fujii T; Aritoku Y; Kagawa Y; Sallam KI; Johdo O; Arisawa A; Tamura T
Biochem Biophys Res Commun; 2011 Jan; 404(1):511-6. PubMed ID: 21144838
[TBL] [Abstract][Full Text] [Related]
55. Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms.
Weber KL; Bolander ME; Rock MG; Pritchard D; Sarkar G
J Orthop Res; 1998 Jan; 16(1):8-14. PubMed ID: 9565067
[TBL] [Abstract][Full Text] [Related]
56. Osteoinductive ability of confluent Saos-2 cell correlates with enhanced expression of bone morphogenetic proteins.
Raval P; Hsu HH; Anderson HC
J Orthop Res; 1996 Jul; 14(4):605-10. PubMed ID: 8764870
[TBL] [Abstract][Full Text] [Related]
57. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
van den Wijngaard A; Mulder WR; Dijkema R; Boersma CJ; Mosselman S; van Zoelen EJ; Olijve W
Mol Endocrinol; 2000 May; 14(5):623-33. PubMed ID: 10809227
[TBL] [Abstract][Full Text] [Related]
58. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
Mancino M; Strizzi L; Wechselberger C; Watanabe K; Gonzales M; Hamada S; Normanno N; Salomon DS; Bianco C
J Cell Physiol; 2008 Apr; 215(1):192-203. PubMed ID: 17941089
[TBL] [Abstract][Full Text] [Related]
59. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
[TBL] [Abstract][Full Text] [Related]
60. [Osteoporosis and bone morphogenetic protein (BMP)].
Higuchi C; Nakase T
Nihon Rinsho; 2005 Oct; 63 Suppl 10():439-43. PubMed ID: 16279679
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
